EBIT at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
Plus components not separately reported this period.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's EBIT?
- Vera Therapeutics (VERA) reported EBIT of -$125.13M in Q1 2026.
- How has Vera Therapeutics's EBIT changed year-over-year?
- Vera Therapeutics's EBIT decreased by 118.8% year-over-year, from -$57.19M to -$125.13M.
- What is the long-term trend for Vera Therapeutics's EBIT?
- Over 4 years (2021 to 2025), Vera Therapeutics's EBIT has grown at a 74.0% compound annual growth rate (CAGR), from -$34.4M to -$315.47M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.